• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 28, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Traumatic Venous Sinus Thrombosis: Anticoagulation Benefit Remains Uncertain in 14-Year Study

by
October 28, 2026
in Health
Reading Time: 3 mins read
0
Traumatic Venous Sinus Thrombosis: Anticoagulation Benefit Remains Uncertain in 14-Year Study

Traumatic Venous Sinus Thrombosis: Anticoagulation Benefit Remains Uncertain in 14-Year Study

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Traumatic cerebral venous sinus thrombosis, a rare but dangerous complication of head injury, remains one of the most management-challenging conditions in neurocritical care. A new retrospective cohort study from a level 1 trauma center in Melbourne, Australia, published in Neurocritical Care, has now documented how the condition was identified, treated and resolved in 138 patients over more than fourteen years, and its central message is sobering: the clinical benefit of anticoagulation in this setting remains unproven.

The researchers identified patients from the Alfred Health Trauma Registry and hospital coding data between 1 January 2010 and 30 June 2024. Because accurate diagnosis matters, venous imaging was reviewed by two neuroradiologists to confirm the tCVST diagnosis and characterize each thrombus. The condition was confirmed in 138 patients, representing an incidence of 0.9% within the center’s traumatic brain injury population. All-cause inpatient mortality was 10.9%, corresponding to 15 deaths among the cohort.

Anticoagulation, which is often used to prevent intracranial complications of venous sinus thrombosis, was administered to 78 patients, or 56.5% of the cohort. Treatment began a median of five days after diagnosis, with an interquartile range of two to nine days. Importantly, the decision to anticoagulate was not made in a vacuum: patients who received anticoagulation generally had less severe traumatic injuries, as measured by the Injury Severity Score and admission Glasgow Coma Scale, but were more likely to have occlusive thrombosis. This pattern of selection highlights the central confounding problem in tCVST research, since concurrent traumatic brain injury and other injuries complicate treatment decisions and make it difficult to isolate the effect of any single therapy.

Among the 123 patients who survived to hospital discharge, 93 underwent follow-up venous imaging from day 14 onward. Complete recanalization, meaning the blocked venous sinus reopened, was achieved in 57% of these patients by their final available imaging. The primary outcome of the study was discharge destination, with recanalization assessed as a secondary outcome, reflecting the clinical reality that functional recovery after head trauma depends on far more than the state of the venous sinuses alone.

The imaging analysis yielded two clear radiographic predictors of poorer recanalization: occlusive thrombosis and involvement of multiple sinuses. Patients whose thrombus completely occluded a sinus, or whose thrombus extended across several sinuses, were less likely to achieve complete reopening on follow-up scans. Strikingly, however, the study identified no association between anticoagulation and recanalization, a finding that will resonate with clinicians who have long lacked consensus guidelines for this condition.

The authors conclude that traumatic CVST is a rare complication of head injury with multiple confounders influencing outcomes and uncertain optimal management, and that the clinical benefit of anticoagulation in this cohort requires further investigation. As a single-center retrospective study, the findings describe practice patterns and associations rather than establishing causal treatment effects, and the authors themselves frame their results as a call for further investigation rather than a change in practice.

Subject of Research: Management and outcomes of traumatic cerebral venous sinus thrombosis after head injury

Article Title: Management and Outcomes in Traumatic Cerebral Venous Sinus Thrombosis

Article References: Richardson, T. E., Balabanski, A. H., Moses, J., Colman, B., Churilov, L., Whiriskey, R., Kam, A., Mathew, J., & Cloud, G. C. (2026). Management and Outcomes in Traumatic Cerebral Venous Sinus Thrombosis. Neurocritical Care. https://doi.org/10.1007/s12028-026-02687-w

Image Credits: AI Generated

DOI: 10.1007/s12028-026-02687-w

Keywords: traumatic cerebral venous sinus thrombosis, traumatic brain injury, anticoagulation, sinus recanalization, retrospective cohort study, neurocritical care, level 1 trauma center, injury severity score, venous imaging, inpatient mortality, Management, Outcomes

News Source: Ophelia Keating. (October 28, 2026). Traumatic Venous Sinus Thrombosis: Anticoagulation Benefit Remains Uncertain in 14-Year Study. Scienmag.

Tags: anticoagulationinjury severity scoreinpatient mortalitylevel 1 trauma centermanagementneurocritical careoutcomesretrospective cohort studysinus recanalizationTraumatic Brain Injurytraumatic cerebral venous sinus thrombosisvenous imaging
Share12Tweet7Share2ShareShareShare1

Related Posts

Clinician education program improves pain outcomes in long COVID care trial

Clinician education program improves pain outcomes in long COVID care trial

October 28, 2026
Digestive Enzyme Combination Eased Functional Dyspepsia Symptoms in 12-Day Indian Study

Digestive Enzyme Combination Eased Functional Dyspepsia Symptoms in 12-Day Indian Study

October 28, 2026

Small Follow-Up Study Tracks Child Development After High Prenatal Stress

October 28, 2026

Ruxolitinib in cold storage solution preserves heart function in aged donor mice

October 28, 2026

POPULAR NEWS

  • Family Physicians in Türkiye Back Pharmacist-Led Medication Management, Study Finds

    Family Physicians in Türkiye Back Pharmacist-Led Medication Management, Study Finds

    29 shares
    Share 12 Tweet 7
  • ECG data and early radiology reports add little to ICU mortality prediction from structured records

    29 shares
    Share 12 Tweet 7
  • Fire Severity Drives Nonlinear Shifts in Subalpine Forest Soil Carbon

    29 shares
    Share 12 Tweet 7
  • New benchmark exposes persistent weaknesses in AI molecular design tools

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tiny Peptide Model Shows How Cobalt and Cysteine Oxidize Together in Nitrile Hydratase Maturation

Immunoglobulins and Efgartigimod dampen neuronal activity in rat cortical cultures

Three Records, One Tax: When Digital Ledgers Agree, Evasion Runs Out of Room

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.